ASLAN Pharmaceuticals To Host KOL Panel Discussion On Treatment Options For Atopic Dermatitis Patients With An Inadequate Response To Dupilumab

Press/Media

Period30 Apr 2024

Media coverage

1

Media coverage

  • TitleASLAN Pharmaceuticals To Host KOL Panel Discussion On Treatment Options For Atopic Dermatitis Patients With An Inadequate Response To Dupilumab
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date30/04/24
    PersonsPeter Lio
View all 1
View less